Failure to detect increased glomerular proteoglycan quantity during the development of nephropathy could be partly explained by assuming that they are secreted into the mesangial matrix, partly to form complexes with TGF-β1 and partly to be cleared via the vasculature or the urinary tract [36], [37]. This evidence concerns the gene TGFB1 and kidney disorder.